Evidence map›Paper›PMID 41974652›Full record

ArticleCell death discovery2026

Enhanced precision in cell culture analytics: leveraging artificial intelligence for unbiased and non-destructive assessment of cell growth and viability.

Cheung Pang Wong, Nasrin Khazamipour, Soroush Aalibagi, Sukrit Kapoor, Louise Ramos, Joya Maria Saade, Casper Dolleris, Janny Marie L Peterslund, Daria Golnarian, Negin Farivar and 2 more

Abstract read
In one paragraph

Article in Cell death discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Cheung Pang WongVancouver Prostate Centre, Vancouver, BC, Canada.
Nasrin KhazamipourVancouver Prostate Centre, Vancouver, BC, Canada.
Soroush AalibagiSnapCyte Solutions Inc., Vancouver, BC, Canada.
Sukrit KapoorSnapCyte Solutions Inc., Vancouver, BC, Canada.
Louise RamosSnapCyte Solutions Inc., Vancouver, BC, Canada.
Joya Maria SaadeSnapCyte Solutions Inc., Vancouver, BC, Canada.
Casper DollerisSnapCyte Solutions Inc., Vancouver, BC, Canada.
Janny Marie L PeterslundSnapCyte Solutions Inc., Vancouver, BC, Canada.
Daria GolnarianSnapCyte Solutions Inc., Vancouver, BC, Canada.
Negin FarivarVancouver Prostate Centre, Vancouver, BC, Canada.
Mads DaugaardVancouver Prostate Centre, Vancouver, BC, Canada. mads.daugaard@ubc.ca.ORCID http://orcid.org/0000-0001-8383-055X
Nader Al NakouziVancouver Prostate Centre, Vancouver, BC, Canada. nalnakouzi@prostatecentre.com.

Funding

Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre (Skin Research Training Centre) 519572Mitacs IT37367
6 · The paper itself

Abstract

Precise assessment of cell growth, count, and viability is a prerequisite for biological and medical research. Traditional cell analytics involve manual processes, such as cell counting or reagent-based approaches that are user-dependent and prone to bias. Semi-automated systems for counting cells, tracking cell growth, and determining viability have been introduced over the past decades. However, these methods are often time-consuming, require labeling steps, and involve costly instrumentation and consumables. Changes in cell growth and/or viability create biological patterns that can be interpreted by artificial intelligence (AI). Here, we report the development and validation of SnapCyte™, an AI application that performs accurate, unbiased, label- and reagent-free cell analyses from basic cell culture images. Using cell lines with diverse morphologies in various culture conditions, we generated a comprehensive and fully annotated image database that was used for AI education. Convolutional neural networks were employed for cell localization and iterative training loops until a stable performance of >95% accuracy was obtained for all readouts. The fully trained AI demonstrated high Precision and Recall and performed with greater accuracy and less variation as compared to standard methods. As the SnapCyte analyses are performed on cell images only, data acquisition is non-invasive to the experimental setup, enabling real-time use of cells in downstream assays. In summary, SnapCyte is a fast and accurate cell analytics platform, resistant to user variations and independent of reagents or specific equipment, with improved performance over current cell analytics methodologies.

Identifiers

PMID41974652
PMCPMC13183963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.